A Study of IBI363 in Subjects with Advanced Solid Malignancies

Clinical trial NCT06281678 · RECRUITING

Trial details

NCT number: NCT06281678
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Non-small Cell Lung Cancer Colorectal Cancer Renal Cell Cancer

Start date: 2024-04-08
Primary completion: 2026-03-01
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.